Date

Monday, 26 June 2023

Location

Online
European Medicines Agency, Amsterdam, the Netherlands

Event summary

Building upon the experience of the submission of real-world evidence for regulatory purpose and the conclusions of previous activities around data standardisation, metadata, data quality and DARWIN EU®, this workshop aims to:

  • Discuss important challenges related to measuring and characterising data quality in the context of RWE generation.
  • Familiarise stakeholders with the approach used in drafting of considerations on Real-World Data linked to the EU Data Quality Framework.
  • Discuss recent use of RWE in the regulatory context and share lessons learned.
  • Look back at the European Medicines Regulatory Network response to the COVID-19 pandemic and reflect on learnings and impact on the way we use RWE to address public health emergencies.
  • Collect input from experts in the field and learn from existing experiences.
  • Get multi-stakeholders’ input to identify ways to enable further use and continue to establish the value of RWE in regulatory processes.

Video recording

Documents

How useful do you find this page?